GlassScriptPhysician profile
Michael James Burton
NPI 1407160559
$10,902.31
in general payments reported to CMS, 2019-2025
27 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,766 · 2020: $450 · 2021: $287 · 2022: $7,963 · 2023: $16.32 · 2024: $130 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356 · Education: $80.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.58 |
| Education | $80.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,890.72 | 2022-2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $726.65 | 2019-2024 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $311.53 | 2019-2021 | |
| Mylan Specialty L.P. | $248.89 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $199.16 | 2022-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.23 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $142.85 | 2019 | |
| Chiesi USA, INC. | $132.01 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $121.72 | 2019-2025 | Uptravi, Opsynvi |
| Insmed, INC. | $114.90 | 2019 | |
| United Therapeutics Corporation | $94.79 | 2019 | |
| Pulmonx Corporation | $91.15 | 2021 | |
| Grifols USA, LLC | $90.54 | 2019-2025 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $74.80 | 2019 | |
| Genzyme Corporation | $69.53 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $69.14 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.74 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $63.04 | 2019-2020 | |
| Advanced Respiratory, INC | $30.60 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $29.98 | 2020 | |
| Electromed, INC. | $25.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.91 | 2020 | |
| Karl Storz Endoscopy-America | $21.75 | 2019 | |
| Verona Pharma, INC. | $20.28 | 2025 | Ohtuvayre |
| Boston Scientific Corporation | $19.29 | 2025 | Varithena Administration Pack |
| Genentech USA, INC. | $15.24 | 2019 | |
| Nabriva Therapeutics, Plc | $13.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Burton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.